Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Given starts small US study of next-generation PillCam Colon

This article was originally published in Clinica

Executive Summary

Given Imaging has started a 50-patient US trial of its PillCam Colon 2 video capsule to confirm procedures and logistics. The company plans to use this information in a larger trial that, if positive, will support its 510(k) application to the US FDA, for colorectal cancer screening in patients unwilling to undergo standard colonoscopy. The Yoqneam, Israel-based firm launched the next-generation device in Europe in November 2009 after CE marking it in September (www.clinica.co.uk, 23 November 2009). Given now plans to expand its European sales efforts for the product, and will also launch it in Canada and several Latin American countries. PillCam Colon 2 provides “superior imaging” over the original PillCam Colon device, Given claims. Neither device is currently approved in the US.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT096411

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel